Statin Use, Lipids, and 3-Hydroxy-3-Methyl-Glutaryl Coenzyme A Reductase Inhibition on Risk of Idiopathic Pulmonary Fibrosis

Saved in:
Bibliographic Details
Published inClinical therapeutics Vol. 46; no. 1; pp. 79 - 81
Main Authors Zhao, Sizheng Steven, Alton, Philip, Rogers, Kira, Hughes, David M.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.01.2024
Elsevier Limited
Subjects
Biobanks
Body mass index
Coenzyme A
Fibrosis
High density lipoprotein
HMG-CoA reductase
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects
idiopathic pulmonary fibrosis
Idiopathic Pulmonary Fibrosis - drug therapy
Internal Medicine
LDL cholesterol
Lipids
Lung diseases
Mendelian randomization
Observational studies
Oxidoreductases
Pulmonary fibrosis
Statins
Triglycerides
United Kingdom > UK
idiopathic pulmonary fibrosis
Mendelian randomization
LDL cholesterol
HMG-CoA reductase
statins
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ISSN:0149-2918
1879-114X
1879-114X
DOI:10.1016/j.clinthera.2023.10.018